Following the indications from pathogenesis, we evaluated whether GDF-15 shares a relationship with biomarkers involved in the development of its cardinal features (hepcidin as a regulatory molecule of anemia of chronic disease, IL-6 as a major myeloma cytokine, and novel molecules of tubular and glomerular injury). The gene discussed is IL6; the disease is anemia.